Spotify teams up with Peloton to launch global fitness content hub
Spotify is increasing its push beyond music and podcasts as the company on Monday announced a new fitness category partnership...
Health care industry
FDA fast-tracks psychedelic drug research following Trump executive order
FILE PHOTO: Psilocybin or "magic mushrooms" are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA)...
Amazon launches GLP-1 weight loss program, promising'fast, convenient' access
Amazon GLP-1 treatmentSource: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new program...
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.Lilly...
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Piotr Swat | Lightrocket | Getty ImagesAs its high-margin compounded GLP-1 business evolves, Hims & Hers Health may be finding...
Trump nominates Erica Schwartz as CDC director
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March...
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't...
Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers
Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the Action for...
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based...
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Texas, Sept. 23, 2025.Antranik Tavitian |...
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
A tick (Ixodida) - carrier for several diseases of humans and animals, for exampel the dangerous Lyme disease, babesiosis, anaplasmosis,...
The price of menstrual products is skyrocketing from inflation, tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024. Dado Ruvic |...
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients,...
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.Kyle Grillot | Bloomberg | Getty...
Inside the booming business of wellness third spaces and membership clubs
A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn't...
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human...
Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the U.S., targeting...
How the 'K-shaped' economy is showing up at two big U.S. gyms
Two of the largest U.S. gym operators delivered the same headline in their latest earnings reports: strong growth.But beneath the...
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,...
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby...
